GW501506 Cardarine 15mg – 50 Tablets
$ 63.60
- GW501516, commonly known as Cardarine, is grouped within the SARM research category in common naming convention despite having no androgen receptor activity whatsoever, it is a PPAR delta (peroxisome proliferator activated receptor delta) agonist, placing it mechanistically alongside SR9009 rather than true SARMs like LGD-4033 or S23. This formulation delivers 15mg per tablet in a 50 count format, consistent with the concentration most frequently referenced in preclinical Cardarine research literature. PPAR delta is a nuclear receptor that functions as a master regulator of fatty acid oxidation and metabolic gene expression in skeletal muscle, adipose tissue, and the liver. Cardarine’s agonist activity at PPAR delta upregulates genes involved in fatty acid transport and beta-oxidation, shifting cellular metabolic preference toward fat utilisation over glucose; a mechanism that has generated extensive preclinical research into its effects on endurance capacity, lipid profile modulation, and metabolic syndrome research models. Unlike SR9009’s Rev ErbA mediated circadian gene repression, Cardarine’s PPAR delta activation operates through a distinct nuclear receptor pathway with its own independent transcriptional targets, despite both compounds sharing the broader metabolic research classification and frequent product category grouping alongside SARMs. Cardarine’s research history includes a notable and widely referenced safety finding long term high dose rodent studies identified increased incidence of multiple cancer types, a finding that has made it one of the most extensively cited cautionary examples in PPAR agonist research literature and a frequently referenced case study in discussions of carcinogenicity risk assessment for nuclear receptor targeting compounds. This research finding is a relevant consideration in comparative metabolic compound research and distinguishes Cardarine’s risk profile discussion from SR9009 and other metabolic research compounds in CSD’s range. This formulation is stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior. Store in a cool, dry place away from direct light and heat. Intended for research purposes only. Commonly researched alongside SR9009 in comparative PPAR and Rev ErbA metabolic pathway studies. Browse CSD’s full SARM and metabolic research range for complete sourcing.
RAD140 (10mg) (50 Tablets)
LGD-4033 (10mg) (50 Tablets)
MK-2866 (10mg) (50 Tablets)